Document is current

Any future updates will be listed below

Erster Erythrozyten-Reifungs-Aktivator bei Low-Risk-MDS zugelassen

Crossref DOI link: https://doi.org/10.1007/s15004-025-0874-4

Published Online: 2025-02-20

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark